心房心肌病:心脏病管理中的有用概念还是短暂风尚?
本文评述心房心肌病这一概念,基于欧洲心律协会等四家学会的共识文件,探讨其定义、病理、影像及对心律失常的影响。作者认为心房心肌病可能是房颤相关卒中风险的独立因素及心律失常进展的决定因素,但其临床价值需精心设计的临床试验验证。
要点
- 心房心肌病可能是房颤相关卒中风险的独立贡献因素。
- 心房心肌病特性可能指导房颤的卒中预防、节律维持和心率控制。
- 该术语的临床价值需精心设计的临床试验来最终确定。
核心结论
- 心房心肌病概念可能具有临床价值,但需临床试验验证其指导房颤管理的作用。
研究设计与样本
- 基于欧洲心律协会、心律学会、亚太心律学会和拉丁美洲心脏刺激与电生理学会代表准备的共识文件的评述。
主要发现
- 证据提示心房心肌病是房颤相关卒中风险的独立贡献因素。
- 心房心肌病是心律失常进展的决定因素。
临床怎么用
- 心房心肌病特性可能指导房颤的卒中预防、节律维持和心率控制。
局限性
- 需精心设计的临床试验评估潜在应用并最终定义该术语的价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The term atrial cardiomyopathy, which has been used sporadically in the medical literature, was recently the subject of a detailed Consensus Document prepared by representatives of the European Heart Rhythm Association, Heart Rhythm Society, Asia-Pacific Heart Rhythm Society, and Sociedad Latinoamericana de Estimulación Cardiaca y Electrofisiología. They discussed aspects of the definition, histopathology, atrial-specific physiology, atrial pathology, impact on arrhythmia occurrence, imaging, mapping, and ablation. Here, the authors consider critically the added clinical value of this concept and its meaningfulness. They review evidence implicating atrial cardiomyopathy as an independent contributor to the risk of stroke associated with atrial fibrillation and as a determinant of arrhythmia progression. The issue of classification is considered and the authors discuss how atrial cardiomyopathic properties might guide stroke prevention, rhythm maintenance, and rate control in atrial fibrillation. Carefully designed clinical trials are needed to evaluate these potential applications, and will ultimately define the value of this terminology.
引用
- Guichard JB, Nattel S. Atrial Cardiomyopathy: A Useful Notion in Cardiac Disease Management or a Passing Fad? J Am Coll Cardiol. 2017. PMID: 28774383. doi:10.1016/j.jacc.2017.06.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。